Navigation Links
MAP Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Unit Dose Budesonide Collaboration with AstraZeneca
Date:2/3/2009

MOUNTAIN VIEW, Calif., Feb. 3 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the waiting period under the Hart-Scott-Rodino Act for its Unit Dose Budesonide (UDB) worldwide agreement with AstraZeneca has expired, and the agreement is now effective. Under this agreement, MAP Pharmaceuticals and AstraZeneca will jointly develop and commercialize UDB, MAP Pharmaceuticals' proprietary nebulized formulation of budesonide for the potential treatment of asthma in children. Expiration of the waiting period triggers an up-front payment to MAP Pharmaceuticals of $40 million.

MAP Pharmaceuticals and AstraZeneca will develop UDB in the United States, and AstraZeneca has rights to develop and commercialize UDB outside of the United States. Under the agreement, AstraZeneca will be responsible for future UDB development costs, and AstraZeneca will reimburse MAP Pharmaceuticals for the costs of future UDB development activities with respect to United States registration incurred by MAP Pharmaceuticals.

Under the terms of the agreement, AstraZeneca will pay MAP Pharmaceuticals an additional $35 million upon the successful achievement of primary endpoint and safety results in the currently ongoing Phase 3 clinical trial of UDB. In addition, upon the occurrence of certain events and conditions, MAP Pharmaceuticals is eligible to receive up to $240 million in other potential development and regulatory milestones. The agreement also provides for additional progressively demanding sales performance-related milestone payments of up to $585 million in the event the product is a considerable commercial success.

AstraZeneca also will support and fund the establishment of a MAP Pharmaceuticals sales force to co-promote UDB in the United States for a certain period of time after product launch. MAP Pha
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... A quality built chicken coop condo with a wheel ... to raise chickens on a pasture. By installing a wheel ... have a chicken tractor that stands up to being moved around ... it is able to flex to uneven ground without losing its ... are fertilized, and it will help provide the chickens with fresh ...
(Date:5/6/2015)... The Canton Group is joining Lardarius Webb ... charity softball game. The event takes place on Friday, May ... years guests include Joe Flacco, John Harbaugh, Ed Reed and ... if you are interested in attending. , The Canton ... SOAR Baltimore and The CollegeBound Foundation , ...
(Date:5/6/2015)... 06, 2015 Animals make just as good ... also good for your health. An Ohio veterinarian ... increase he's seeing with health advantages of owning a pet. ... it comes to pet ownership, there are proven health benefits ... Scott Leffler of the Animal Medical Center of ...
(Date:5/6/2015)... Anitha Nallari, MD has joined ... Inc. in Columbus, OH. Dr. Nallari will see patients ... in breast cancer, lung cancer, GI and gallbladder cancer, head ... benign hematology. , Dr. Anitha Nallari is Board ... American Board of Internal Medicine. She completed her medical education ...
(Date:5/6/2015)... May 06, 2015 Anitoa Systems, (“Anitoa”), ... with Zhejiang University of China, has successfully demonstrated a ... CMOS bio-optical sensor. Anitoa’s handheld qPCR is shown ... DNA and RNA’s, including hepatitis B, C, and E. ... 4 copies per sample and over 9 orders of ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... NY The American Cancer Society and the National Palliative ... grants to researchers at 12 institutions for studies aimed at ... The studies will be conducted over the next two years. ... 51 grants totaling almost $7 million. These grants, which are ...
... ... first in the Albany, NY area to have Laser-Assisted Smartlipo Triplex™ technology to offer ... and faster healing times. , ... Albany-Schenectady-Troy, NY (PRWEB) May 12, 2010 -- Traditional liposuction has been available ...
... doses of metformin, Avandia cut risk by two-thirds in study, ... pre-diabetes, a low-dose combination of two diabetes drugs -- metformin ... type 2 diabetes, new research shows. , The study found ... by two-thirds in those taking the drug combo compared to ...
... between 18 and 25, researchers say , WEDNESDAY, June 2 ... what they believe -- or hope -- is true: Teenagers ... study found that as teens become young adults, many -- ... impulsive behaviors decreases, along with the amount of alcohol they ...
... be tailored to individual patients, researchers say , , WEDNESDAY, ... can benefit from deep brain stimulation in either one of ... The Veterans Affairs researchers compared two different targets in the ... and the globus pallidus interna (GPi) -- both of which ...
... very few if any, really know how likely they are ... to change, thanks to a new discovery by an international ... access people,s personal risk for skin cancer. In ... Journal ( http://www.fasebj.org ), these researchers describe for the ...
Cached Medicine News:Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 2Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 3Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 4Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 5Health News:Breakthrough In Liposuction Comes To New York's Capital District 2Health News:Drug Combo Staves Off Type 2 Diabetes 2Health News:Drug Combo Staves Off Type 2 Diabetes 3Health News:Impulsive Behavior, Drinking Decline in Early Adulthood 2Health News:Deep Brain Stimulation Works in Two Sites for Parkinson's Disease 2Health News:Deep Brain Stimulation Works in Two Sites for Parkinson's Disease 3Health News:Sun-induced skin cancer: new discovery permits doctors to assess genetic risk 2
(Date:5/6/2015)... , May 6, 2015 In ... malaria and tuberculosis combined[1]. Approximately 40 percent of cancer cases ... the right treatment[3]. Together with Elekta, ministries of health in ... their radiation therapy infrastructures and save lives. More ... from radiation therapy[4] during the course of their disease, either ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ... of the "Asia-Pacific Internal Trauma Fixation Devices ... and Forecast To 2019" report to their ... Devices market is estimated to grow at a ... such as technological advancement, rising incidences of road ...
(Date:5/6/2015)... , May 6, 2015   GenSpera, Inc. ... Compositions" has entered the national phase application process in 17 ... Japan , China , ... States . When awarded, the resulting patent application will ... its entire platform technology, including its lead drug candidate, mipsagargin, ...
Breaking Medicine Technology:Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... Rigid plastic. Convenient. Single use. Kit comprises: 1 ... 2 Child; Miller 3 Medium Ad.; 1 Mac 2 ... Large Ad. 1 Chrome Handle, Standard, 1 Nylon Carrying ... sturdy yet lightweight way to take your disposable laryngoscopes ...
... Lamp supplied with blade. Oxygen port. ... on any standard/conventional handle allowing you ... without the potential confusion from different ... offer an easy and cost effective ...
... disposable blades are an economical option ... labor by requiring no sterilization, disinfecting, ... disposable blades help eliminate cross-contamination., ... concern for possible crosscontamination from AIDS, ...
... Medical's Articulating Tip Laryngoscopes are ... the Industry. The articulating tip ... providing an improved view of ... Fiber Optic styles. We guarantee ...
Medicine Products: